Search

Search Constraints

You searched for: Author/Creator Huang, Jee-Fu

Search Results

1. A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C. Issue 4 (6th September 2006)

2. An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions. (8th April 2019)

3. Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B. (29th November 2020)

4. Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies. Issue 2 (February 2019)

5. Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C. Issue 4 (April 2019)

6. Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus–infected patients. Issue 2 (February 2019)

7. Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study. Issue 5 (5th May 2019)

8. Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH). (August 2020)

9. Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, Taiwan. Issue 3 (3rd March 2021)